Fat and Hidden Liver Cancer
Sailish Honap, Jude A. Oben – 27 February 2021
Chronic Fatigue Persists in a Significant Proportion of Female Patients After Transplantation for Primary Sclerosing Cholangitis
Ewa Wunsch, Anna Stadnik, Beata Kruk, Benedykt Szczepankiewicz, Katarzyna Kotarska, Marcin Krawczyk, Barbara Górnicka, Maciej Wójcicki, Piotr Milkiewicz – 27 February 2021 – Chronic fatigue and an impairment of general health‐related quality of life (HRQoL) are frequently reported by patients with primary sclerosing cholangitis (PSC). Studies on patients with primary biliary cholangitis (PBC) suggest that, unlike pruritus, fatigue may not be ameliorated by liver transplantation (LT). However, there are few data regarding the assessment of fatigue before and after transplantation in PSC.
Coordination, Cost, and Changing Epidemiology—Considerations in the Hepatitis C Care Cascade
Nancy Yang, Andrew Muir – 27 February 2021
Hepatitis C Virus Prevalence, Screening, and Treatment Among People Who Are Incarcerated in Canada: Leaving No One Behind in the Direct‐Acting Antiviral Era
Sofia R. Bartlett, Jane Buxton, Adam Palayew, Camila A. Picchio, Naveed Z. Janjua, Nadine Kronfli – 27 February 2021
Wilson’s Disease and Iron Overload: Pathophysiology and Therapeutic Implications
Kevin Pak, Sarah Ordway, Brett Sadowski, Margaux Canevari, Dawn Torres – 27 February 2021
Fat and Hidden Liver Cancer
Sailish Honap, Jude A. Oben – 27 February 2021
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: A Patient‐Friendly Summary of the 2019 AASLD Guidelines
Michael L. Volk, Nancy Reau – 27 February 2021
A Case of Rapid Decline in Alcohol‐Associated Liver Disease
Aashesh Verma, Donald Jensen – 27 February 2021
Hepatic Steatosis and Ectopic Fat Are Associated With Differences in Subcutaneous Adipose Tissue Gene Expression in People With HIV
Curtis L. Gabriel, Fei Ye, Run Fan, Sangeeta Nair, James G. Terry, John Jeffrey Carr, Heidi Silver, Paxton Baker, LaToya Hannah, Celestine Wanjalla, Mona Mashayekhi, Sam Bailin, Morgan Lima, Beverly Woodward, Manhal Izzy, Jane F. Ferguson, John R. Koethe – 26 February 2021 – Persons with human immunodeficiency virus (PWH) have subcutaneous adipose tissue (SAT) dysfunction related to antiretroviral therapy and direct viral effects, which may contribute to a higher risk of nonalcoholic fatty liver disease compared with human immunodeficiency virus–negative individuals.